Pfizer  

235 East 42nd Street
New York,  NY  10017

United States
https://www.pfizer.com/
  • Booth: Virtual


https://www.advancinghemonccare.com/

At Pfizer, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars, including seven therapies to treat Hematologic malignancies. We have taken bold new approaches over the past decade to translate scientific research into transformative medicines for people living with blood cancer. For the millions living with blood cancer today and for those diagnosed tomorrow, we work tirelessly to deliver on our mission: Breakthroughs that change patients' lives.


 Press Releases